Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

Contributed by: PR Newswire

Tags

Medinol-FIH-study

More Like This

PR Newswire associated0

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

PR Newswire associated0

Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study

PR Newswire associated0

Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study

PR Newswire associated0

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology

PR Newswire associated0

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

PR Newswire associated0

AuriGen Medical Pioneers Next-Generation Atrial Fibrillation Technology with First-in-Human Success

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead